标题
Small Molecule Inhibitors of CRM1
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-05-07
DOI
10.3389/fphar.2020.00625
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma
- (2019) Ajai Chari et al. NEW ENGLAND JOURNAL OF MEDICINE
- FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models
- (2018) Cristina Corno et al. BIOCHEMICAL PHARMACOLOGY
- Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma
- (2016) Fabrice Jardin et al. AMERICAN JOURNAL OF HEMATOLOGY
- A cellular reporter to evaluate CRM1 nuclear export activity: functional analysis of the cancer-related mutant E571K
- (2016) Iraia García-Santisteban et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies
- (2016) Z A Hing et al. LEUKEMIA
- Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells
- (2015) Mingshan Niu et al. CANCER BIOLOGY & THERAPY
- Piperlongumine is a novel nuclear export inhibitor with potent anticancer activity
- (2015) Mingshan Niu et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy
- (2015) Weimin Gao et al. Journal of Thoracic Oncology
- Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination
- (2015) Jeffery D Haines et al. NATURE NEUROSCIENCE
- Targeting nucleocytoplasmic transport in cancer therapy
- (2015) Richard Hill et al. Oncotarget
- Oridonin induces NPM mutant protein translocation and apoptosis in NPM1c+ acute myeloid leukemia cells in vitro
- (2014) Fei-fei Li et al. ACTA PHARMACOLOGICA SINICA
- KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma
- (2014) Yun Zheng et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma
- (2014) Mariko Yoshimura et al. CANCER SCIENCE
- Components and regulation of nuclear transport processes
- (2014) Bastien Cautain et al. FEBS Journal
- Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
- (2014) Kaushal Parikh et al. Journal of Hematology & Oncology
- CRM1 Is a Direct Cellular Target of the Natural Anti-cancer Agent Plumbagin
- (2014) Xuejiao Liu et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Elevated expression of the nuclear export protein, Crm1 (exportin 1), associates with human oesophageal squamous cell carcinoma
- (2014) PAULINE J. VAN DER WATT et al. ONCOLOGY REPORTS
- Prognostic impact and targeting of CRM1 in acute myeloid leukemia
- (2013) K. Kojima et al. BLOOD
- Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276
- (2013) J Schmidt et al. LEUKEMIA
- CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications
- (2013) Y-T Tai et al. LEUKEMIA
- CRM1 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas
- (2013) Fang Zhou et al. MEDICAL ONCOLOGY
- p53 SUMOylation promotes its nuclear export by facilitating its release from the nuclear export receptor CRM1
- (2013) Aleixo Santiago et al. MOLECULAR BIOLOGY OF THE CELL
- Structural basis for cooperativity of CRM1 export complex formation
- (2013) T. Monecke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1
- (2013) Qingxiang Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of a Truncation Mutant of the Nuclear Export Factor CRM1 Provides Insights into the Auto-Inhibitory Role of Its C-Terminal Helix
- (2013) Cyril Dian et al. STRUCTURE
- CRM1 Is a Cellular Target of Curcumin: New Insights for the Myriad of Biological Effects of an Ancient Spice
- (2013) Mingshan Niu et al. TRAFFIC
- Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia
- (2012) R. Lapalombella et al. BLOOD
- Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia
- (2012) P. Ranganathan et al. BLOOD
- Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors
- (2012) Ori Kalid et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- A 2.1-Å-Resolution Crystal Structure of Unliganded CRM1 Reveals the Mechanism of Autoinhibition
- (2012) Natsumi Saito et al. JOURNAL OF MOLECULAR BIOLOGY
- CRM1 Blockade by Selective Inhibitors of Nuclear Export Attenuates Kidney Cancer Growth
- (2012) Hiromi Inoue et al. JOURNAL OF UROLOGY
- Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
- (2012) J Etchin et al. LEUKEMIA
- Nuclear export of proteins and drug resistance in cancer
- (2011) Joel G. Turner et al. BIOCHEMICAL PHARMACOLOGY
- CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity
- (2011) K. Sakakibara et al. BLOOD
- Protein localization in disease and therapy
- (2011) M.-C. Hung et al. JOURNAL OF CELL SCIENCE
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- The cytotoxic styryl lactone goniothalamin is an inhibitor of nucleocytoplasmic transport
- (2010) Jean-Yves Wach et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- An allosteric mechanism to displace nuclear export cargo from CRM1 and RanGTP by RanBP1
- (2010) Masako Koyama et al. EMBO JOURNAL
- The Anti-inflammatory Prostaglandin 15-Deoxy-Δ12,14-PGJ2Inhibits CRM1-dependent Nuclear Protein Export
- (2010) Mark Hilliard et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anguinomycins and Derivatives: Total Syntheses, Modeling, and Biological Evaluation of the Inhibition of Nucleocytoplasmic Transport
- (2010) Simone Bonazzi et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- NES consensus redefined by structures of PKI-type and Rev-type nuclear export signals bound to CRM1
- (2010) Thomas Güttler et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- High content screening: seeing is believing
- (2010) Fabian Zanella et al. TRENDS IN BIOTECHNOLOGY
- Suppression of HDAC nuclear export and cardiomyocyte hypertrophy by novel irreversible inhibitors of CRM1
- (2009) Lauren Monovich et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Identification of Nuclear Export Inhibitors with Potent Anticancer Activity In vivo
- (2009) S. C. Mutka et al. CANCER RESEARCH
- Structural basis for leucine-rich nuclear export signal recognition by CRM1
- (2009) Xiuhua Dong et al. NATURE
- Structural basis for assembly and disassembly of the CRM1 nuclear export complex
- (2009) Xiuhua Dong et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- EXPRESSION OF CRM1 IN HUMAN GLIOMAS AND ITS SIGNIFICANCE IN P27 EXPRESSION AND CLINICAL PROGNOSIS
- (2009) Aiguo Shen et al. NEUROSURGERY
- Crystal Structure of the Nuclear Export Receptor CRM1 in Complex with Snurportin1 and RanGTP
- (2009) T. Monecke et al. SCIENCE
- Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer
- (2008) Aurelia Noske et al. CANCER
- CRM1-Mediated Nuclear Export of Proteins and Drug Resistance in Cancer
- (2008) Joel Turner et al. CURRENT MEDICINAL CHEMISTRY
- The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation
- (2008) Pauline J. van der Watt et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now